Big Moving Stock chart patterns and volume.
|Nasdaq:||GOOG NFLX BIIB AMZN IBB PCYC TSLA AMGN SLXP COST MNST WYNN GMCR AAPL MDVN VRTX CELG Z BMRN|
|Nyse:||ACT V LNKD AGN PCP IVV GS SPG FDX MMM NOC PXD HUM IBM TWC APD BA BDX ANTM|
|New Highs:||BIIB IBB PPG PCYC TWC DDS LH UHS AET CRI HSP VMC TGT HCA BMY HAIN CNC LAMR APH|
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.